Skip to main content
PMC home page
Gut logoLink to Gut
. 2002 May;50(Suppl 4):iv23–iv25. doi: 10.1136/gut.50.suppl_4.iv23

Assessment of outcome in dyspepsia: has progress been made?

v Veldhuyzen
PMCID: PMC1867700  PMID: 11953342

Full Text

The Full Text of this article is available as a PDF (86.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergner M., Bobbitt R. A., Carter W. B., Gilson B. S. The Sickness Impact Profile: development and final revision of a health status measure. Med Care. 1981 Aug;19(8):787–805. doi: 10.1097/00005650-198108000-00001. [DOI] [PubMed] [Google Scholar]
  2. Blum A. L., Talley N. J., O'Moráin C., van Zanten S. V., Labenz J., Stolte M., Louw J. A., Stubberöd A., Theodórs A., Sundin M. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. N Engl J Med. 1998 Dec 24;339(26):1875–1881. doi: 10.1056/NEJM199812243392602. [DOI] [PubMed] [Google Scholar]
  3. Dimenäs E., Glise H., Hallerbäck B., Hernqvist H., Svedlund J., Wiklund I. Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens? Scand J Gastroenterol. 1993 Aug;28(8):681–687. doi: 10.3109/00365529309098272. [DOI] [PubMed] [Google Scholar]
  4. Gilvarry J., Buckley M. J., Beattie S., Hamilton H., O'Morain C. A. Eradication of Helicobacter pylori affects symptoms in non-ulcer dyspepsia. Scand J Gastroenterol. 1997 Jun;32(6):535–540. doi: 10.3109/00365529709025095. [DOI] [PubMed] [Google Scholar]
  5. Guyatt G. H., Veldhuyzen Van Zanten S. J., Feeny D. H., Patrick D. L. Measuring quality of life in clinical trials: a taxonomy and review. CMAJ. 1989 Jun 15;140(12):1441–1448. [PMC free article] [PubMed] [Google Scholar]
  6. Jaeschke R., Singer J., Guyatt G. H. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989 Dec;10(4):407–415. doi: 10.1016/0197-2456(89)90005-6. [DOI] [PubMed] [Google Scholar]
  7. McColl K., Murray L., El-Omar E., Dickson A., El-Nujumi A., Wirz A., Kelman A., Penny C., Knill-Jones R., Hilditch T. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med. 1998 Dec 24;339(26):1869–1874. doi: 10.1056/NEJM199812243392601. [DOI] [PubMed] [Google Scholar]
  8. Stewart A. L., Hays R. D., Ware J. E., Jr The MOS short-form general health survey. Reliability and validity in a patient population. Med Care. 1988 Jul;26(7):724–735. doi: 10.1097/00005650-198807000-00007. [DOI] [PubMed] [Google Scholar]
  9. Svedlund J., Sjödin I., Dotevall G. GSRS--a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci. 1988 Feb;33(2):129–134. doi: 10.1007/BF01535722. [DOI] [PubMed] [Google Scholar]
  10. Talley N. J., Janssens J., Lauritsen K., Rácz I., Bolling-Sternevald E. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group. BMJ. 1999 Mar 27;318(7187):833–837. doi: 10.1136/bmj.318.7187.833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Veldhuyzen van Zanten S. J., Cleary C., Talley N. J., Peterson T. C., Nyrén O., Bradley L. A., Verlinden M., Tytgat G. N. Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol. 1996 Apr;91(4):660–673. [PubMed] [Google Scholar]
  12. Wenger N. K., Mattson M. E., Furberg C. D., Elinson J. Assessment of quality of life in clinical trials of cardiovascular therapies. Am J Cardiol. 1984 Oct 1;54(7):908–913. doi: 10.1016/s0002-9149(84)80232-5. [DOI] [PubMed] [Google Scholar]
  13. Wiklund I., Bardhan K. D., Müller-Lissner S., Bigard M. A., Bianchi Porro G., Ponce J., Hosie J., Scott M., Weir D., Fulton C. Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study Group. Ital J Gastroenterol Hepatol. 1998 Feb;30(1):19–27. [PubMed] [Google Scholar]
  14. el-Omar E. M., Banerjee S., Wirz A., McColl K. E. The Glasgow Dyspepsia Severity Score--a tool for the global measurement of dyspepsia. Eur J Gastroenterol Hepatol. 1996 Oct;8(10):967–971. doi: 10.1097/00042737-199610000-00006. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES